Pharma Aids Limited reported unaudited earnings results for the third quarter and nine months ended March 31, 2018. For the quarter, the company’s EPS was BDT 4.29 as against BDT 2.27 for January-March 2017. For the nine months, EPS was BDT 12.34 as against BDT 7.17 for July 2016-March 2017. NOCFPS was BDT 1.98 for July 2017-March 2018 as against negative NOCFPS of BDT 2.90 for July 2016-March 2017. NAV per share was BDT 58.14 as on March 31, 2018.